Terug
Dagbereik
€ 13,03
€ 13,80
52-Weeksbereik
€ 3,35
€ 16,33
Volume
137.766
50D / 200D Gem.
€ 13,74
/
€ 10,26
Vorige Slotkoers
€ 13,28
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,5 | 0,2 |
| P/B | 2,0 | 2,9 |
| ROE % | -26,1 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -55,54M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-26,13%
ROIC-18,96%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,03
Current Ratio27,50
Interest Coverage0,00
Waardering
P/E Ratio
-8,50
Forward P/EN/A
P/B Ratio1,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -59,98M |
| ROE | -26,13% | ROA | -21,68% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -55,54M |
| ROIC | -18,96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 27,50 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,50 | Forward P/E | N/A |
| P/B Ratio | 1,95 | P/S Ratio | N/A |
| PEG Ratio | 11,51 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -10,90% | ||
| Market Cap | 509,64M | Enterprise Value | 442,28M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 50,00M | 0,0 | 0,0 |
| Net Income | -59,98M | -42,26M | 22,72M | -24,25M | -29,00M |
| EPS (Diluted) | -2,17 | -2,18 | 0,90 | -0,97 | -1,15 |
| Gross Profit | -323.000,0 | -258.000,0 | 50,00M | -329.000,0 | 0,0 |
| Operating Income | -68,06M | -50,89M | -16,08M | -22,72M | -28,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 276,64M | 212,85M | 130,39M | 50,64M | 70,52M |
| Total Liabilities | 15,65M | 14,78M | 198,32M | 11,37M | 8,93M |
| Shareholders' Equity | 260,99M | 198,07M | -67,94M | 39,27M | 61,59M |
| Total Debt | 8,25M | 6,26M | 193,19M | 5,85M | 4,91M |
| Cash & Equivalents | 75,60M | 21,94M | 15,53M | 5,57M | 4,63M |
| Current Assets | 267,92M | 206,39M | 127,71M | 48,39M | 69,78M |
| Current Liabilities | 9,74M | 9,97M | 5,48M | 7,55M | 3,67M |